YBX1 and lung cancer: Mechanistic studies show that NSUN2 regulates the m5C modification of QSOX1, and YBX1 enhances QSOX1 translation in an m5C-dependent manner, thereby promoting resistance to EGFR-mutant lung cancer (2).